Metallothioneins, Ageing and Cellular Senescence: A Future Therapeutic Target

E-ISSN： 1873-4286|19|9|1753-1764

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.19, Iss.9, 2013-03, pp. : 1753-1764

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cellular FLICE-inhibitory protein: an attractive therapeutic target?

By Micheau Olivier

Expert Opinion on Therapeutic Targets, Vol. 7, Iss. 4, 2003-08 ,pp. : 559-573

Informa Healthcare

Access to resources Recommend Favorite

Cellular Redox Pathways as a Therapeutic Target in the Treatment of Cancer

By Montero Alberto J.

Drugs, Vol. 71, Iss. 11, 2011-07 ,pp. : 1385-1396

Adis International

Access to resources Recommend Favorite

Molecular and Cellular Pathways as a Target of Therapeutic Hypothermia: Pharmacological Aspect

Current Neuropharmacology, Vol. 10, Iss. 1, 2012-03 ,pp. : 80-87

Bentham Science Publishers

Access to resources Recommend Favorite

Roles and Therapeutic Potential of Metallothioneins in Neurodegenerative Diseases

Current Pharmaceutical Biotechnology, Vol. 14, Iss. 4, 2013-03 ,pp. : 408-413

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial (Cellular Senescence and Inflammation: Advances and Therapeutic Targets in Aging and Major Age-Related Diseases)

Current Pharmaceutical Design, Vol. 19, Iss. 9, 2013-01 ,pp. : 1673-1674

Bentham Science Publishers

Access to resources Recommend Favorite